Pfizer CEO Albert Bourla has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing that his ...

By Sriparna Roy and Bhanvi Satija (Reuters) -Shares of global vaccine makers were muted on Tuesday as investors and analysts ...

Dividend stocks are one way to shield yourself from the market volatility. While all stocks carry a certain element of risk, ...

Merck won FDA approval for a shot that protects against RSV, the most common cause of hospitalization among infants ...

Shares of major vaccine makers Moderna and Pfizer held steady even as U.S. health secretary Robert F. Kennedy Jr. abruptly ...

WASHINGTON: Health Secretary Robert F Kennedy Jr has fired all members sitting on a US Centers for Disease Control and Prevention panel of vaccine experts and is reconstituting the committee, his ...

Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and ...

RNs working at UCSD Medical Center plan to rally Tuesday alongside UC nurses statewide to mark the start of their contract ...

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...

Despite some recent setbacks to its sickle cell disease (SCD) pipeline, Pfizer is plowing ahead in improving education around ...

Axsome Therapeutics has hit a costly snag in its mission to bring esreboxetine to market for fibromyalgia. | Axsome ...

Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 8:00 AM ETCompany ParticipantsAlbert Bourla - Chairman of ...